Atlas Trials

Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Clinical trial NCT03848832 · TERMINATED

Trial details

NCT number
NCT03848832
Sponsor
Jazz Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Rett SyndromeRTT
Start date
2019-07-29
Primary completion
2021-01-21
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.